Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules: a Multicenter, Prospective, Randomized, Double-blind, Placebo-controlled Study

NCT06423235 is registered in ClinicalTrials.gov with Xintian Pharmaceutical as lead sponsor.

NCT NCT06423235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06423235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules: a Multicenter, Prospective, Randomized, Double-blind, Placebo-controlled Study
Lead sponsor
Xintian Pharmaceutical
Phase
Phase 4
Overall status
Recruiting
Start date
July 30, 2024
Completion date
July 30, 2028
Enrollment
234 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid nodule